Customer Success Specialist
About the job
- Excellent English communication skills are mandatory.
- Ability to communicate with customers in the United States and United Kingdom.
- A minimum Matric or O Levels qualification is required.
- Strong problem-solving and interpersonal skills are required.
- Basic knowledge of Microsoft Office or Google Workspace is required.
- Ability to multitask across CRM tools and communication platforms is required.
- Candidates must be at least 18 years old and have a valid CNIC.
- Handle high-volume inbound calls, chats, and emails from customers in the United States and United Kingdom.
- Assist with order tracking, delivery updates, returns, refunds, and account-related queries.
- Provide accurate information about products, pricing, shipping, and policies.
- Achieve first-call resolution through effective problem-solving.
- Maintain a professional, empathetic, and customer-first approach.
- Follow client standard operating procedures, quality standards, and compliance guidelines.
- Use CRM systems to log interactions and manage customer cases.
- Achieve key performance indicators including customer satisfaction (CSAT), net promoter score (NPS), average handle time (AHT), and quality scores.
- Escalate complex issues appropriately while ensuring customer satisfaction.
- Stay updated on process changes and system updates.
- A Bachelor's degree is preferred.
- A neutral, American, or British accent is preferred.
- Experience in international call center or eCommerce support is a plus.
About the company
Ibex Biosciences focuses on discovering, validating, and producing biotechnology solutions for health and ecological challenges. Its product portfolio includes therapeutic antibodies, gene therapy, and stem cell programs, as well as diagnostic antibodies for Immunohistochemistry (IHC) to improve biopsy accuracy. The company advances its products by conducting exploratory R&D on projects that may not yet be validated in public research, then develops and commercializes these technologies through licensing, partnerships, and direct sales to healthcare and research institutions. A key differentiator is Ibex’s diversified, internally driven pipeline and its mix of therapeutics and diagnostics, alongside active engagement in grant funding and patenting. The company’s goal is to bring proprietary biotech innovations to market to enhance patient outcomes and health-related research, addressing significant cancer-related and other health challenges.
Company Size
1-10
Company Stage
Early VC
Total Funding
$4.2M
Headquarters
North Bethesda, Maryland
Founded
2015
Get referred to IBEX
See people who can refer or advise you
Simplify's Take
What believers are saying
- Ibex keeps an open 506(c) offering, signaling active capital formation in 2026.
- The 2022 CD147 patent supports oncology and inflammation licensing conversations.
- Anti-MIF VHH development continues, with animal-model testing already disclosed.
What critics are saying
- Ibex has no disclosed commercial products, leaving revenue dependent on financing.
- The open Regulation D offering implies dilution risk and financing pressure through 2026.
- Without clinical validation, the company risks becoming a perpetual patent shop.
What makes IBEX unique
- North Bethesda-based Ibex Biosciences focuses on antibody, gene-therapy, and stem-cell programs.
- Its 2026 pipeline spans CD147 antibodies, anti-MIF VHHs, and PCBP1 stem-cell methods.
- Ibex still controls early patentable assets, including 2022 CD147 publication.
Help us improve and share your feedback! Did you find this helpful?
Benefits
- Performance Bonus